ATE269090T1 - Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv - Google Patents

Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv

Info

Publication number
ATE269090T1
ATE269090T1 AT95905398T AT95905398T ATE269090T1 AT E269090 T1 ATE269090 T1 AT E269090T1 AT 95905398 T AT95905398 T AT 95905398T AT 95905398 T AT95905398 T AT 95905398T AT E269090 T1 ATE269090 T1 AT E269090T1
Authority
AT
Austria
Prior art keywords
animal model
hiv
treat leukemia
testing drugs
drugs
Prior art date
Application number
AT95905398T
Other languages
English (en)
Inventor
Benjamin P Chen
Christopher C Fraser
Irving Weissman
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE269090T1 publication Critical patent/ATE269090T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95905398T 1993-12-17 1994-12-16 Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv ATE269090T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16929393A 1993-12-17 1993-12-17
PCT/US1994/014485 WO1995016452A2 (en) 1993-12-17 1994-12-16 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems

Publications (1)

Publication Number Publication Date
ATE269090T1 true ATE269090T1 (de) 2004-07-15

Family

ID=22615057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95905398T ATE269090T1 (de) 1993-12-17 1994-12-16 Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv

Country Status (8)

Country Link
US (1) US6770260B1 (de)
EP (1) EP0787003B1 (de)
JP (1) JPH09506626A (de)
AT (1) ATE269090T1 (de)
AU (1) AU1402495A (de)
CA (1) CA2174729A1 (de)
DE (1) DE69433851D1 (de)
WO (1) WO1995016452A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102725400A (zh) * 2009-06-29 2012-10-10 麻省理工学院 制造人源化的非人类哺乳动物的方法
US20140256639A1 (en) * 2013-02-14 2014-09-11 The Regents Of The University Of California Peptoid neutralizing agents

Also Published As

Publication number Publication date
EP0787003B1 (de) 2004-06-16
WO1995016452A3 (en) 1995-10-05
CA2174729A1 (en) 1995-06-22
WO1995016452A2 (en) 1995-06-22
JPH09506626A (ja) 1997-06-30
AU1402495A (en) 1995-07-03
EP0787003A2 (de) 1997-08-06
DE69433851D1 (de) 2004-07-22
US6770260B1 (en) 2004-08-03

Similar Documents

Publication Publication Date Title
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
ATE192045T1 (de) Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
ATE170082T1 (de) Verfahren zur wachstumshemmung von leukämischen zellen durch her-2-protein-zeilen
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
CH621224B (de) Mittel zur wachstumshemmung von mikroorganismen und algen.
ATE149573T1 (de) Gerbmittel und gerbverfahren
ATE269090T1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE3674513D1 (de) Verwendung von hygromycin und epihygromycin zur behandlung von dysentrie bei schweinen.
AT383142B (de) Vorrichtung zur kultivierung und behandlung von biokatalysatoren
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE3864615D1 (de) Verfahren und anordnung zur behandlung von bei verbrennung schadstoffe freisetzendem holz, bzw. holzkohle.
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE3680172D1 (de) Verfahren zur behandlung von protistezellen.
ATE365718T1 (de) Substituierte 11-phenyl-dibenzazepin-verbindungen,die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten
KR870007191A (ko) 유기백금착물 및 이를 사용한 종양 치료방법
ATE30244T1 (de) Verfahren und vorrichtung zur kultivierung von mikroorganismen.
UA14243A1 (uk) Спосіб визhачеhhя зеаралеhоhа у білковому продукті

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties